Vector BioPharma

About:

Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.

Website: https://www.vectorbiopharma.com/

Top Investors: Versant Ventures

Description:

Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.

Total Funding Amount:

$30M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Basel, Basel-Stadt, Switzerland

Founded Date:

2021-01-01

Contact Email:

info(AT)vectorbiopharma.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-08-10

IPO Status:

Private

Industries: